Chiesi Farmaceutici S.p.A.

Reportlinker Adds Pulmonary Drug Delivery Technologies - A Global Market Perspective.
PR Newswire; 11/18/2009; 2277 words; ...Bans the Use of CFC's in Metered Dose Inhalers...Inhalers 19 Trinity Chiesi Pharmaceuticals Introduces...SymbicortA' 22 Dey, L.P Unveils Perforomist...Corporation (USA) 24 Chiesi Farmaceutici SpA (Italy) 24 Consort...UK) 24 Dey L.P. (USA) 24 GlaxoSmithKline...

Publication No. WO/2009/135579 Published on Nov. 12, Assigned to Chiesi Farmaceutici for 8-hydroxy-5- [(1r)-1-hydroxy-2- [[(1r) -2-(4-methoxyphenyl) -1-methylethyl] Amino] Ethyl] -2(1h)-Quinolinone Monohydrochloride Polymorph (Italian Inventors)
US Fed News Service, Including US State News; 11/13/2009; 408 words; ...methylethyl] amino] ethyl] -2(1h)-quinolinone monohydrochloride. The patent has been assigned to Chiesi Farmaceutici S.p.a., Parma, Italy. According to an abstract posted by the World Intellectual Property Organization: "The...

Patent No. 07601336 Issued on Oct. 13, Assigned to Chiesi Farmaceutici S.p.A. for Pharmaceutical aerosol composition
US Fed News Service, Including US State News; 10/15/2009; 387 words; ...composition .The inventors were issued U.S. Patent No. 07601336 on Oct. 13. The patent has been assigned Chiesi Farmaceutici S.p.A., Parma. According to the abstract released by the U.S. Patent & Trademark Office...

Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results.
PR Newswire; 8/11/2009; 4619 words; ...million strategic transaction with Chiesi Farmaceutici S.p.A. closes, adding a further...principles. Accordingly, the Company's financial statements for periods...specifically noted otherwise, the Company's financial results do not include...

Patent No. 7,531,692 Issued on May 12, Assigned to Chiesi Farmaceutici for Phenylalkanecarboxylic Acid Derivative (Italian Inventors)
US Fed News Service, Including US State News; 8/4/2009; 375 words; ...diseases. The inventors were issued U.S. Patent No. 7,531,692 on May 12. The patent has been assigned to Chiesi Farmaceutici S.p.A., Parma. According to the abstract released by the U.S. Patent & Trademark Office...